Your search returned 3 results.

Results
	1.	Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials. [electronic resource] by Jabbour, Serge Seufert, Jochen Scheen, Andre Bailey, Clifford J Karup, Cathrina Langkilde, Anna M Producer: 20181211 In: Diabetes, obesity & metabolism vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). [electronic resource] by McMurray, John J V DeMets, David L Inzucchi, Silvio E Køber, Lars Kosiborod, Mikhail N Langkilde, Anna M Martinez, Felipe A Bengtsson, Olof Ponikowski, Piotr Sabatine, Marc S Sjöstrand, Mikaela Solomon, Scott D Producer: 20200909 In: European journal of heart failure vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	DECLARE-TIMI 58: Participants' baseline characteristics. [electronic resource] by Raz, Itamar Mosenzon, Ofri Bonaca, Marc P Cahn, Avivit Kato, Eri T Silverman, Michael G Bhatt, Deepak L Leiter, Lawrence A McGuire, Darren K Wilding, John P H Gause-Nilsson, Ingrid A M Langkilde, Anna M Johansson, Peter A Sabatine, Marc S Wiviott, Stephen D Producer: 20190114 In: Diabetes, obesity & metabolism vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)